P L F Giangrande Selected Research

P L F Giangrande Research Topics

9	Hemophilia A (Haemophilia) 05/2017 - 03/2002
1	Hepatitis C 05/2017
1	Joint Diseases (Joint Disease) 09/2012
1	Hemorrhage 03/2009
1	Anaphylaxis (Anaphylactic Shock) 05/2007
1	Hemophilia B (Haemophilia B) 05/2007
1	Body Weight (Weight, Body) 07/2004
1	von Willebrand Diseases (von Willebrand's Disease) 08/2003
1	Thrombosis (Thrombus) 05/2003
1	Wounds and Injuries (Trauma) 05/2003
1	Acute Coronary Syndrome 10/2002
1	Thrombocytopenia (Thrombopenia) 10/2002
1	Venous Thromboembolism 10/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2002

4	Factor VIII (Coagulation Factor VIII)IBA 09/2012 - 03/2002
4	AntibodiesIBA 05/2007 - 10/2002
2	Blood Coagulation Factors (Coagulation Factor)IBA 05/2017 - 05/2003
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 05/2007 - 07/2004
1	Antiviral Agents (Antivirals)IBA 05/2017
1	factor VII clotting antigenIBA 07/2004
1	recombinant FVIIa (rFVIIa)FDA Link 07/2004
1	Factor VII (Proconvertin)IBA 07/2004
1	von Willebrand FactorIBA 08/2003
1	Fondaparinux (Arixtra)FDA Link 10/2002
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2002
1	Heparin (Liquaemin)FDA LinkGeneric 10/2002
1	Enoxaparin (Lovenox)FDA LinkGeneric 10/2002
1	Sucrose (Saccharose)IBA 03/2002
1	Human Serum Albumin FDA LinkGeneric 03/2002
1	human F8 protein FDA Link 03/2002